http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112014023809-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97ef5401e6b556cb3204b62a2601903f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07
filingDate 2013-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f26154a51adab1bef7d1a0567f30613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4492debb8e71ee593bd90d037ee4b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1c2133b6f080a061b95731edcc46aa9
publicationDate 2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112014023809-A2
titleOfInvention methods and compositions for the treatment of atherosclerotic vascular diseases
abstract abstract "methods and compositions for treating atherosclerotic vascular diseases" The present invention provides methods and compositions for treating atherosclerotic vascular diseases by cyclohexenone compounds. in some embodiments, the compound in the methods inhibits pdf-stimulated proliferation or migration of smooth muscle cells. in some embodiments, atherosclerosis is associated with coronary artery disease, aneurysm, arteriosclerosis, myocardial infarction, embolism, stroke, thrombosis, angina, vascular plaque inflammation, vascular plaque rupture, kawasaki disease, calcification or inflammation. in some embodiments, the compound reduces low density lipoprotein (ldl) cholesterol in the subject. in some embodiments, the compound maintains a normal to low density lipoprotein (ldl) cholesterol level in the subject.
priorityDate 2012-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516292

Total number of triples: 30.